Loblaw Companies Limited · TSX:L
Loblaw Companies — Q3 2024 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Oct 5, 2024
Slide 1: Supplementary Slides Q3 2024
SUPPLEMENTARY SLIDES Q3 2024 For the periods ended October 5, 2024 and October 7, 2023 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q3 2024 (millions of Canadian dollars unless otherwise noted) Q3 2024 Q3 2023 % Change (1) Consolidated Revenue $18,538 $18,265 ↑ +1.5% Adjusted EBITDA $2,069 $1,926 ↑ +7.4% Adjusted EBITDA Margin 11.2 % 10.5 % ↑ 70bps Adjusted Net Earnings Avaliable to Common Sh
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q3 2024 (millions of Canadian dollars unless otherwise noted) Q3 2024 Q3 2023 % Change (1) Total Retail Revenue $18,259 $17,982 ↑ 1.5% Retail Revenue - Food $12,966 $12,843 ↑ 1.0% Retail Revenue - Drug $5,293 $5,139 ↑ 3.0% Pharmacy and Healthcare Services $2,78
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q3 2024 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +0.5% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +2.9